ArticleCureus2024
Allergic Rhinitis Symptoms and Impact Assessment (ARSIA) of Public Community in Saudi Arabia: A National Cross-Sectional Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting hepatitis B virus-associated nephropathy: efficacy and challenges of current antiviral treatments.Clinical and experimental medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Allergic rhinitis (AR) is a common inflammatory condition of the nasal mucosa in Saudi Arabia, triggered by various allergens. It significantly impacts daily life, affecting sleep quality, social interactions, and productivity. Despite its prevalence, AR is often underdiagnosed and undertreated in the region. Methods This national cross-sectional study was conducted in February 2024 using an online survey distributed via social media and Google Forms. Participants were Saudi Arabian residents with self-reported AR. The allergic rhinitis symptoms and impact assessment (ARSIA) questionnaire was used and translated into Arabic. A total of 262 participants completed the survey. Data were analyzed using SPSS, with descriptive statistics and chi-square tests to explore relationships between variables. Results The study included 262 participants, with a nearly balanced gender representation of 133 (50.8%) females and 129 (49.2%) males and a predominant age group of >30 years with 140 individuals (53.4%). The majority were Saudi nationals, 244 (93.1%). Educational levels varied, with undergraduates being the largest group of 132 (50.4%) respondents. Concerning smoking, 189 respondents (72.1%) never smoked. A high prevalence of allergen sensitivity was noted, with smoke (98.1%) and medications (99.2%) being the most common triggers. Medication use varied, with 114 (43.5%) participants not using any medication. Continuous symptoms were reported by 140 (53.4%) of participants, and 161 participants (61.5%) classified their symptoms as moderate to severe. Significant differences were observed based on nationality, education level, and social status concerning symptom severity. Conclusion AR significantly impacts the Saudi Arabian population, with high allergen sensitivity and varied medication use. The study underscores the need for improved diagnosis and treatment strategies, considering the unique environmental and demographic factors in the region. Further research is necessary to develop effective interventions tailored to the local context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.